Nektar Management to Present at the H.C. Wainwright 2nd Annual Autoimmune & Inflammatory Disease Virtual ConferencePR Newswire • about 1 month ago
Nektar Management to Present at the H.C. Wainwright 2nd Annual Autoimmune & Inflammatory Disease Virtual Conference Nektar Management to Present at the H.C. Wainwright 2nd Annual Autoimmune...
Share to Feed
GSA Capital Partners LLP lifted its position in shares of Nektar Therapeutics (NASDAQ:NKTR Free Report) by 931.5% during the 3rd quarter, according to its most recent disclosure with the SEC...
Nektar Therapeutics (NASDAQ:NKTR Free Report) had its price target increased by Jefferies Financial Group from $0.50 to $1.00 in a report published on Wednesday, Benzinga reports. Jefferies...
Nektar Therapeutics (NASDAQ:NKTR Free Report) Equities research analysts at William Blair lowered their Q1 2024 earnings estimates for shares of Nektar Therapeutics in a report...
Shares of Nektar Therapeutics (NASDAQ:NKTR Get Free Report) have been assigned an average recommendation of Hold from the five ratings firms that are presently covering the...
Nektar Therapeutics (NKTR) Q4 2023 Earnings Call Transcript...
Nektar Therapeutics Announces Initiation of Phase 2b Clinical Study Evaluating Rezpegaldesleukin in Patients with Severe to Very Severe Alopecia Areata Nektar Therapeutics Announces Initiation of...
Nektar Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results Nektar Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results PR Newswire SAN FRANCISCO, March 4, 2024...
Nektar Therapeutics Announces $30 Million Private Placement Financing with TCGX Nektar Therapeutics Announces $30 Million Private Placement Financing with TCGX PR Newswire SAN FRANCISCO, March 4...
Nektar Therapeutics Q4 2023 Earnings Preview...